HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)

Organon

Status and phase: Completed; Phase 3

Conditions: Hypertension; Type 2 Diabetes Mellitus

Treatments: Drug: Comparator : ramipril /Duration of Treatment : 8 Weeks; Drug: MK0954A, losartan potassium (+) hydrochlorothiazide (HYZAAR) / Duration of Treatment : 8 Weeks

Study type: Interventional

Funder types: Industry

Identifiers

NCT00480805

0954A-245

2007_554

Details and patient eligibility

About

A study to test the safety and efficacy of HYZAAR as compared to Ramipril in patients with type 2 diabetes mellitus (high blood sugar) and hypertension (high blood pressure).

Enrollment: 312 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient is at least 18 years old, has been diagnosed with type 2 diabetes mellitus

Exclusion criteria

• Patient has renal disease, malignant hypertension, uncontrolled type 2 diabetes mellitus, history of stroke, TIA (Transient Ischemic Attacks) , or heart disease

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind